Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP367503.RAUZIbIJRfOns6KnbYGKFLTT2j0QrUvuvUS-KO0UAFC6k130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP367503.RAUZIbIJRfOns6KnbYGKFLTT2j0QrUvuvUS-KO0UAFC6k130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP367503.RAUZIbIJRfOns6KnbYGKFLTT2j0QrUvuvUS-KO0UAFC6k130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP367503.RAUZIbIJRfOns6KnbYGKFLTT2j0QrUvuvUS-KO0UAFC6k130_provenance.
- NP367503.RAUZIbIJRfOns6KnbYGKFLTT2j0QrUvuvUS-KO0UAFC6k130_assertion description "[Similarly, asoprisnil decreased epidermal growth factor (EGF), insulin-like growth factor-I (IGF-I), and transforming growth factor (TGF) beta mRNA and protein expression, as well as EGF receptor, IGF-IR alpha, and TGF RII protein expression in leiomyoma cells but not in cultured normal myometrial cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP367503.RAUZIbIJRfOns6KnbYGKFLTT2j0QrUvuvUS-KO0UAFC6k130_provenance.
- NP367503.RAUZIbIJRfOns6KnbYGKFLTT2j0QrUvuvUS-KO0UAFC6k130_assertion evidence source_evidence_literature NP367503.RAUZIbIJRfOns6KnbYGKFLTT2j0QrUvuvUS-KO0UAFC6k130_provenance.
- NP367503.RAUZIbIJRfOns6KnbYGKFLTT2j0QrUvuvUS-KO0UAFC6k130_assertion SIO_000772 18089606 NP367503.RAUZIbIJRfOns6KnbYGKFLTT2j0QrUvuvUS-KO0UAFC6k130_provenance.
- NP367503.RAUZIbIJRfOns6KnbYGKFLTT2j0QrUvuvUS-KO0UAFC6k130_assertion wasDerivedFrom befree-20150227 NP367503.RAUZIbIJRfOns6KnbYGKFLTT2j0QrUvuvUS-KO0UAFC6k130_provenance.
- NP367503.RAUZIbIJRfOns6KnbYGKFLTT2j0QrUvuvUS-KO0UAFC6k130_assertion wasGeneratedBy ECO_0000203 NP367503.RAUZIbIJRfOns6KnbYGKFLTT2j0QrUvuvUS-KO0UAFC6k130_provenance.
- befree-20150227 importedOn "2015-02-27" NP367503.RAUZIbIJRfOns6KnbYGKFLTT2j0QrUvuvUS-KO0UAFC6k130_provenance.